Russian Journal of Child Neurology

Русский журнал детской неврологии

2073-88032412-9178

Publishing House ABV Press

264

10.17650/2073-8803-2018-13-3-36-44

ORIGINAL REPORTS

ОРИГИНАЛЬНЫЕ СТАТЬИ

Analysis of the efficacy of antiepileptic drugs in the treatment of infantile spasms and focal epilepsy associated with tuberous sclerosis complex

Анализ эффективности антиэпилептических препаратов в лечении инфантильных спазмов и фокальной эпилепсии, ассоциированной с туберозным склерозом

Grigoryeva

A. V.

Григорьева

А. В.

Russian Federation

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

Антонина Васильевна Григорьева

Отдел эпилептологии и психоневрологии Научно-исследовательского клинического института педиатрии им. акад. Ю.Е. Вельтищева

125412 Москва, ул. Талдомская, 2

ton.grigorjewa2010@yandex.ru

Dorofeeva

M. Yu.

Дорофеева

М. Ю.

Russian Federation

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

125412 Москва, ул. Талдомская, 2

Perminov

V. S.

Перминов

В. С.

Russian Federation

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

125412 Москва, ул. Талдомская, 2

Belousova

E. D.

Белоусова

Е. Д.

Russian Federation

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

125412 Москва, ул. Талдомская, 2

N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России

15072018

133

36442911201829112018

2018

ABV-Press

АБВ-пресс

https://rjdn.abvpress.ru/jour/about/editorialPolicies

https://rjdn.abvpress.ru/jour/article/view/264

tuberous sclerosis complexepilepsyfocal seizuresinfantile spasmsefficacyremissionтуберозный склерозэпилепсияфокальные приступыинфантильные спазмыэффективностьремиссия1.Belousiva E.D. Dorofeeva M.Yu., Pivovarova A.M., Katysheva O.V. Diagnosis of tuberous sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2015;115(5):46–51. (In Russ.).Белоусова Е.Д., Дорофеева М.Ю., Пивоварова А.М., Катышева О.В. Диагностика туберозного склероза. Журнал неврологии и психиатрии им. С.С. Корсакова 2015;115(5):46–51.2.Curatolo P., Jóźwiak S., Nabbout R., TSC Consensus Meeting for SEGA and Epilepsy Management. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 2012;16(6):582–6. PMID: 22695035. DOI: 10.1016/j.ejpn.2012.05.004.3.Curatolo P., Moavero R., de Vries P.J. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 2015;14(7):733–45. PMID: 26067126. DOI: 10.1016/S14744422(15)00069-1.4.Cusmai R., Moavero R., Bombardieri R. et al. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav 2011;22(4):735–9. PMID: 22142783. DOI: 10.1016/j.yebeh.2011.08.037.5.Fallah A., Guyatt G.H., Snead O.C. et al. Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: An Individual Participant Data Meta-Analysis. PLoS One 2013;8(2):e53565. PMID: 23405072. DOI: 10.1371/journal.pone.0053565.6.Fallah A., Weil A.G., Wang S. et al. Costutility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex. Epilepsy Behav 2016;63:79–88. PMID: 27591681. DOI: 10.1016/j.yebeh.2016.07.034.7.Epileptic spasms. Available at: https://www.epilepsydiagnosis.org/seizure/epileptic-spasms-overview.html.8.Jeong A., Nakagawa J.A., Wong M. Predictors of drug resistant epilepsy in tuberous sclerosis complex. J Child Neurol 2017;32(14):1092–8. PMID: 29129154. DOI: 10.1177/0883073817737446.9.Krueger D.A., Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49(4):255–26. PMID: 24053983. DOI: 10.1016/j.pediatrneurol.2013.08.002.10.Lux A.L., Osborne J.P. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004;45(11):1416–28. PMID: 15509243. DOI: 10.1111/j.0013-9580.2004.02404.x.11.Major P., Thiele E.A. Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 2008;13(2):357–60. PMID: 18468492. DOI: 10.1016/j.yebeh.2008.04.001.12.Northrup H., Krueger D.A. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 2013;49(4):243–54.13.Overwater I.E., Bindels-de Heus K., Rietman A.B. et al. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Epilepsia 2015;56(8):1239–45. DOI: 10.1111/epi.13050.14.Roach E.S., Di Mario F.J., Kandt R.S., Northrup H. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. J Child Neur 1999;14(6):401–7. DOI: 10.1177/088307389901400610.15.Saxena A., Sampson J.R. Epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments. Semin Neurol 2015;35(3):269–76. DOI: 10.1055/s-0035-1552616.16.Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58(4):512–21. DOI: 10.1111/epi.13709.17.Zhang B., McDaniel S.S., Rensing N.R., Wong M. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One 2013;8(2);e57445. PMID: 23437388. DOI: 10.1371/journal.pone.0057445.